Market-Specific focus

CLIA-Waived, PoC & OTC

Delivered on 40+ projects, bringing PoC and OTC products to market

We help innovators chart the course to bring diagnostic solutions closer to the patient—whether at the point of care, in urgent care and clinic settings, or through over-the-counter access. Our team blends deep regulatory insight with hands-on experience guiding CLIA-waived studies and submissions, navigating the distinct pathways that decentralized testing demands. We understand the performance, usability, and workflow challenges unique to these environments and design studies that meet those requirements without compromise. From early feasibility through FDA clearance, we provide the strategic direction and operational precision to steer your program confidently from concept to market—ensuring diagnostics that perform reliably wherever care is delivered.

Client Locations

North America: United States and Canada

Europe: UK and Middle East

APAC: South Korea, Japan, India, Taiwan, Singapore, Australia and New Zealand

Study Locations

North America: United States and Canada

Europe: Denmark, Sweden, Finland, Germany, the Netherlands, Spain, France, Italy and the UK

PoC, OTC and Urgent Care Projects

Regulatory, clinical and quality projects

WHERE WE SHINE

Markets

The MDC team has worked with IVD manufacturers across a wide range of therapeutic areas helping to bring diagnostics innovation to market where it’s needed most to impact patients.

Infectious Diseases & Microbiology

Partnered with 40+ infectious disease, microbiology and women's health firms

Clinical Chemistry & Hematology

Delivered on 40+ projects, partnering with clients, bringing clinical chemistry and hematology products to market

CLIA-waived, PoC & OTC

Experts after 60+ projects in point of care and over-the-counter testing

Lets Talk About Your Program

    Connect with our team!

    NO SURPRISES, JUST FORWARD MOMENTUM

    Schedule some time to go over your goals: